New York, NY, March 12, 2021 (GLOBE NEWSWIRE) — Facts and Factors have published a new research report titled “Antibody Drug Conjugates Market by Drugs (Adcetris and Kadcyla), Mechanism of Action (CD30 Antibodies and HER2 Antibodies), Application (Breast Cancer, Lymphoma, and Other Types of Cancer): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2026” .
“According to the research report, the global Antibody Drug Conjugates Market was estimated at USD 2,000 Million in 2019 and is expected to reach USD 4,670 Million by 2026. The global Antibody Drug Conjugates Market is expected to grow at a compound annual growth rate (CAGR) of 12.9% from 2019 to 2026”.
Antibody drug conjugates are usually used to treat cancer and therefore are better and safer than most other cancer therapies. The increased incidence of cancer growth combined with the development of the geriatric population is likely to have an impact on the Antibody-Drug Conjugates market. Moreover, major innovative progressions are likewise adding to drive the development. As estimated by the World Health Organization (WHO), the number of individuals aged 65 years or more is projected to reach 16 % of the total population by 2050, compared to 7% in 2000. Maturing has become a significant hazard factor for various illnesses including cancer and others. Consequently, the developing geriatric populace is projected to drive the development of the market over the figure time frame.
Request Your Free Sample Report of Antibody Drug Conjugates Market @ https://www.fnfresearch.com/sample/antibody-drug-conjugates-market-by-drugs-adcetris-and
(The free sample of this report is readily available on request).
Our Free Sample Report Includes:
- 2020 Updated Report Introduction, Overview, and In-depth industry analysis
- COVID-19 Pandemic Outbreak Impact Analysis Included
- 190+ Pages Research Report (Inclusion of Updated Research)
- Provide Chapter-wise guidance on Request
- 2020 Updated Regional Analysis with Graphical Representation of Size, Share & Trends
- Includes Updated List of table & figures
- Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis
- Facts and Factors research methodology
(Note: The sample of this report is updated with COVID-19 impact analysis before delivery)
Key Questions Answered in this Report
1) What was the impact of COVID-19 on the Antibody Drug Conjugates Market?
2) What is the market size, share of the Antibody Drug Conjugates Market?
3) Who are the top market players in Antibody Drug Conjugates Market?
4) What will be the future market of the Antibody Drug Conjugates Market?
- Market Size & Forecast by Revenue | 2020−2026
- Market Dynamics – Leading trends, growth drivers, restraints, and investment opportunities
- Market Segmentation – A detailed analysis by product, by types, end-user, applications, segments, and geography
- Competitive Landscape – Top key vendors and other prominent vendors
Inquire more about this report before purchase @ https://www.fnfresearch.com/inquiry/antibody-drug-conjugates-market-by-drugs-adcetris-and
(You may enquire a report quote OR available discount offers to our sales team before purchase.)
Impact Analysis of COVID-19 Pandemic on Businesses: Know Short Term and Long Term Impact
Most of the businesses are facing a growing litany of business-critical concerns related to the coronavirus outbreak, including supply chain disruptions, a risk of a recession, and a potential drop in consumer spending. All these scenarios will play out differently across various regions and industries, making accurate and timely market research more essential than ever.
We at Facts and Factors ( http://www.fnfresearch.com ) understand how difficult it is for you to plan, strategize, or make business decisions, and as such, we have your back to support you in these uncertain times with our research insights. Our team of consultants, analysts, and experts has developed an analytical model tool for markets that helps us to assess the impact of the virus more effectively on the industrial markets. We are further implementing these insights into our reports for a better understanding of our clients.
Request COVID-19 Impact Analysis on Businesses: https://www.fnfresearch.com/sample/antibody-drug-conjugates-market-by-drugs-adcetris-and
Impressive financial investments involving technologies and their small distribution are likely to boost the growth of the market. In addition, the increasing use of Antibody Drug Conjugates in different sections of end-users across developing countries is a component that stimulates market growth. However, high capital costs and rigid regulatory regulations are the key factors restricting the growth of the sector.
Industry Major Market Players
- Synthon Holding B.V.
- Seattle Genetics Inc.
- Sanofi S.A.
- Progenics Pharmaceuticals Inc.
- Pfizer Inc.
- Immunomedics Inc.
- Immunogen Inc.
- Genentech Inc.
- Celldex Therapeutics Inc.
- Bayer Healthcare Pharmaceuticals
To know an additional revised 2020 list of market players, request a sample report: https://www.fnfresearch.com/sample/antibody-drug-conjugates-market-by-drugs-adcetris-and
The Antibody Drug Conjugates industry has been segmented on the basis of drugs, application, mechanism of action, and region. The drugs segment is divided into adcetris and kadcyla. The Adcetris division had the largest market share in 2019, with the fastest increase expected in the near future. ADCs have been attracting a lot of interest from both small and major pharmaceutical firms because of effective marketing and advanced technologies.
Further, the mechanism of action segment is classified as HER2 antibodies and CD30 antibodies. Additionally, the application segment is classified as lymphoma, breast cancer, and others. Breast cancer was the largest share in 2019 and is likely to experience greater growth over the coming years due to various factors such as Kadcyla availability and high incidence of breast cancer.
Directly Purchase a copy of the report with TOC @ https://www.fnfresearch.com/buynow/su/antibody-drug-conjugates-market-by-drugs-adcetris-and
The report study further includes an in-depth analysis of industry players’ market shares and provides an overview of leading players’ market position in the Antibody Drug Conjugates sector. Key strategic developments in the Antibody Drug Conjugates market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the Antibody Drug Conjugates market are appropriately highlighted in the report.
The worldwide market for ADC is expected to be driven by the advancement of clinical innovation. The key drivers of the market are the increasing prevalence of cancer, the development of mature populations, and the increase in large populations. Besides, the expanding research exercises on immune response treatments, preclinical examination, more exploration on cutting edge tranquilize revelations, and expanding research on oncology infections and the developing joint effort between research foundations, Biotechnology, and Biopharmaceuticals organizations is likewise going about as a fuel to the market and is relied upon to drive the market of ADC inside the estimate time frame. However, the significant expense of the methodology and the lack of funds can be the restriction for the development of this market.
Request Customized Copy of Report @ https://www.fnfresearch.com/customization/antibody-drug-conjugates-market-by-drugs-adcetris-and
(We customize your report according to your research need. Ask our sales team for report customization.)
The Antibody Drug Conjugates industry has been segmented on the basis of drugs, application, mechanism of action, and region. The drugs segment is divided into adcetris and kadcyla. Further, the mechanism of action segment is classified as HER2 antibodies and CD30 antibodies. Additionally, the application segment is classified as lymphoma, breast cancer, and others.
The world market is categorized as Latin America, APAC, North America, Europe, and the MEA regions. North America is projected to control the global market quickly due to the increasing proliferation of technologically innovative technologies in the countries of the region. This rise in demand is attributed due to increasing individual awareness regarding the usage of advanced healthcare in the region. North America is a very well-established region in terms of medical knowledge and the use of ADCs and makes up most of the established market. However, Asia Pacific is likely to expand at a high CAGR during the forecast time due to the Covid-19 outbreak in Wuhan Province in China and further widespread into neighboring countries.
Browse the full “Antibody Drug Conjugates Market by Drugs (Adcetris and Kadcyla), Mechanism of Action (CD30 Antibodies and HER2 Antibodies), Application (Breast Cancer, Lymphoma, and Other Types of Cancer): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2026” report at https://www.fnfresearch.com/antibody-drug-conjugates-market-by-drugs-adcetris-and
This report segments the Antibody Drug Conjugates market as follows:
Global Antibody Drug Conjugates Market: Drugs Segment Analysis
Global Antibody Drug Conjugates Market: Mechanism of Action Segment Analysis
- CD30 Antibodies
- HER2 Antibodies
Global Antibody Drug Conjugates Market: Application Segment Analysis
- Breast Cancer
KEY REPORT POINTERS & HIGHLIGHTS:
- Statistically Validated Analysis of Historical, Current, and Projected Industry Trends with Authenticated Market Sizes Information and Data in terms of Value and Volume, wherever applicable
- Direct and Indirect Factors that Impacted the Industry as well Projected Rationales expected to affect the industry going forward
- Micro, Meso, Macro, and In-Depth Analysis of Technically relevant and Commercially viable Segments and Sub-segments of the Market
- Historical and Projected Company / Vendor / OEM / Supplier Market Shares, Competitive Landscape, and Player Positioning Data
- Historical and Current Demand (Consumption) and Supply (Production) Scenarios as well as Projected Supply-Demand Scenario Analysis
- Detailed List of Key Buyers and End-Users (Consumers) analyzed as per Regions and Applications
- Value Chain and Supply Chain Analysis along with Horizontal and Vertical Integration Scenarios
- Manufacturing and Production Cost Structure Analysis including Labor Cost, Raw Material Expenses, and Other Manufacturing Expenses, wherever relevant
- Overview of Key Marketing Strategies and Key Sales Channels Adopted in the Market
Cancer Supportive Care Drug Market: https://www.fnfresearch.com/cancer-supportive-care-drug-market-by-product-type-937
Consumer Genomics Market: https://www.fnfresearch.com/consumer-genomics-market-by-application-diagnostics-genetic-relatedness-940
Bladder Cancer Therapeutics Market: https://www.fnfresearch.com/bladder-cancer-therapeutics-market-by-cancer-type-transitional-947
Pharmacokinetics Services Market: https://www.fnfresearch.com/pharmacokinetics-services-market-by-drug-type-large-molecules-979
Pediatric And Adult Hemoconcentrators Market: https://www.fnfresearch.com/pediatric-and-adult-hemoconcentrators-market-by-type-adult-992
About Facts & Factors (FnF Research):
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.
Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Follow Us LinkedIn: https://www.linkedin.com/company/fnfresearch
Follow Us Twitter: https://twitter.com/fnfresearch
Facts & Factors
Email: [email protected]